Investing Profile

Carole Nuechterlein

VC

Photo of Carole Nuechterlein, Managing Partner at Roche Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Michigan Network
54 CONNECTIONS
cb
Roche Venture Fund Managing Partner
8
CompanyStageDateRound SizeTotal Raised
Tioma Therapeutics
Series AAug 2016$86M
$86M
Co-investors: John McKearn (RiverVest), Jill carroll (SR One)
AveXis
Series DSep 2015$65M
Series CJan 2015$10M
$75M
Co-investors: Jonathan Leff (Deerfield Management)
Lysosomal Therapeutics
Series AFeb 2015$20M
Seed RoundMay 2014$4.8M
$24.8M
Co-investors: Clay Thorp (Hatteras Venture Partners), Bruce Booth (Atlas Venture)
Alios BioPharma
Series BApr 2014$41M
Series AJun 2009$24M
Series AFeb 2009$8.4M
$74.4M
Co-investors: Jack Nielsen (Vivo Capital), Jens Eckstein (SR One)
Head, Roche Venture Fund F.Hoffmann-La Roche2001 - Present
General Counsel SangStat1998 - 2001
University of Michigan JD